CN107647410A - 一种复合配比的益生菌粉及其制备方法 - Google Patents
一种复合配比的益生菌粉及其制备方法 Download PDFInfo
- Publication number
- CN107647410A CN107647410A CN201710909932.1A CN201710909932A CN107647410A CN 107647410 A CN107647410 A CN 107647410A CN 201710909932 A CN201710909932 A CN 201710909932A CN 107647410 A CN107647410 A CN 107647410A
- Authority
- CN
- China
- Prior art keywords
- powder
- compound
- probiotic
- probiotic powder
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 124
- 239000006041 probiotic Substances 0.000 title claims abstract description 69
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 69
- 230000000529 probiotic effect Effects 0.000 title claims abstract description 58
- 150000001875 compounds Chemical class 0.000 title claims abstract description 53
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims abstract description 28
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 15
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 15
- 229940041514 candida albicans extract Drugs 0.000 claims abstract description 15
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 15
- 229920001221 xylan Polymers 0.000 claims abstract description 15
- 150000004823 xylans Chemical class 0.000 claims abstract description 15
- 239000012138 yeast extract Substances 0.000 claims abstract description 15
- 229920001202 Inulin Polymers 0.000 claims abstract description 14
- 229920001100 Polydextrose Polymers 0.000 claims abstract description 14
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims abstract description 14
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 14
- 229940029339 inulin Drugs 0.000 claims abstract description 14
- 239000001259 polydextrose Substances 0.000 claims abstract description 14
- 229940035035 polydextrose Drugs 0.000 claims abstract description 14
- 235000013856 polydextrose Nutrition 0.000 claims abstract description 14
- 229940013618 stevioside Drugs 0.000 claims abstract description 14
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims abstract description 14
- 235000019202 steviosides Nutrition 0.000 claims abstract description 14
- 239000000203 mixture Substances 0.000 claims abstract description 12
- 235000020183 skimmed milk Nutrition 0.000 claims abstract description 12
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 240000006024 Lactobacillus plantarum Species 0.000 claims abstract description 9
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims abstract description 9
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims abstract description 9
- 229940072205 lactobacillus plantarum Drugs 0.000 claims abstract description 9
- 244000199866 Lactobacillus casei Species 0.000 claims abstract description 7
- 235000013958 Lactobacillus casei Nutrition 0.000 claims abstract description 7
- 229940017800 lactobacillus casei Drugs 0.000 claims abstract description 7
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims abstract description 6
- 230000008901 benefit Effects 0.000 claims abstract description 6
- 229940009289 bifidobacterium lactis Drugs 0.000 claims abstract description 6
- 241000894006 Bacteria Species 0.000 claims description 15
- 238000011282 treatment Methods 0.000 claims description 14
- 229920001503 Glucan Polymers 0.000 claims description 13
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 claims description 13
- 230000001954 sterilising effect Effects 0.000 claims description 12
- 238000004659 sterilization and disinfection Methods 0.000 claims description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 3
- 235000020166 milkshake Nutrition 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 16
- 230000009286 beneficial effect Effects 0.000 abstract description 8
- 230000036039 immunity Effects 0.000 abstract description 4
- 230000004060 metabolic process Effects 0.000 abstract description 4
- 230000002708 enhancing effect Effects 0.000 abstract description 3
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 abstract 1
- 229920002498 Beta-glucan Polymers 0.000 abstract 1
- 230000007413 intestinal health Effects 0.000 abstract 1
- 235000008935 nutritious Nutrition 0.000 abstract 1
- 230000001151 other effect Effects 0.000 abstract 1
- 239000000047 product Substances 0.000 description 10
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 230000036541 health Effects 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 235000016709 nutrition Nutrition 0.000 description 7
- 206010012735 Diarrhoea Diseases 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 230000035764 nutrition Effects 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 235000013406 prebiotics Nutrition 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 238000005238 degreasing Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 244000228451 Stevia rebaudiana Species 0.000 description 2
- 201000009840 acute diarrhea Diseases 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 235000015096 spirit Nutrition 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
- 241000607528 Aeromonas hydrophila Species 0.000 description 1
- 206010059245 Angiopathy Diseases 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000189115 Catananche Species 0.000 description 1
- 239000004380 Cholic acid Substances 0.000 description 1
- 208000000668 Chronic Pancreatitis Diseases 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241000186605 Lactobacillus paracasei Species 0.000 description 1
- 201000010538 Lactose Intolerance Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010033649 Pancreatitis chronic Diseases 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 235000006092 Stevia rebaudiana Nutrition 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000675 anti-caries Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 235000019416 cholic acid Nutrition 0.000 description 1
- 229960002471 cholic acid Drugs 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 235000013410 fast food Nutrition 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000796 flavoring agent Chemical class 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 208000020694 gallbladder disease Diseases 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000021049 nutrient content Nutrition 0.000 description 1
- 235000006180 nutrition needs Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001184 polypeptide Chemical class 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000765 processed proteins & peptides Chemical class 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/14—Yeasts or derivatives thereof
- A23L33/145—Extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/125—Casei
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/531—Lactis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种复合配比的益生菌粉及其制备方法。所述复合配比的益生菌粉由如下重量百分比的原料制备得到：复合益生菌粉30～35％、脱脂乳粉5～15％、酵母抽提物5～15％、麦芽糊精粉8～16％、燕麦β‑葡聚糖5～10％、菊粉2～8％、甜菊糖3～6％、低聚果糖3～8％、聚葡萄糖3～6％、聚木糖2～10％；所述复合益生菌粉由植物乳杆菌粉、乳双歧杆菌粉、鼠李糖乳杆菌粉、干酪乳杆菌粉按质量比2～3:1～1.5:0.5～1.2:1组成。本发明制备的益生菌粉不仅营养丰富，而且具有促进新陈代谢，有益于肠道健康，改善身体机能，提高免疫力等功效，且具有操作简便、运行可靠，产品贮运要求低、保质期长，生产效益高等优点。
Description
技术领域
本发明属于营养食品技术领域，更具体地，涉及一种复合配比的益生菌粉及其制备方法。
背景技术
益生菌亦称肠益菌，是指能存活于肠道的非致病性微生物。现已有证据指出，益生菌可能帮助肠道内壁免受伤害，对人类的肠胃道疾病具有特殊的功效；也有证据指出益生菌能改善因服用抗生素而产生的相关副作用，如肠胃炎、急性腹泻，也能改善乳糖不耐症的症状。益生菌正在成为人们防治疾病维护健康的重要产品，它既有见效快的近期效果，如在预防和治疗急慢性腹泻、便秘，改善肠胃功能等；还有显著的远期效果，如通过降低人体内毒素水平、改善营养状况、帮助肝细胞生长、提高人体免疫力等而起到了保护肝脏、辅助改善肝病症状的作用；对于用化学、放射、免疫抑制剂治疗中的副反应导致菌群失调的症状如食欲减低、乏力、白细胞计数下降等，益生菌产品也可以改善前述症状，提高抗病能力。
同时，由于肠道是外界的传感器，来自外界的所有东西最终都在肠道终结。人体肠道中的益生菌对健康非常有益，能帮助免疫系统抵挡更危险的细菌，能将营养成分分解，甚至还能控制身体储存脂肪。圣路易斯华盛顿大学基因科学中心主任戈登认为，西方人更易发胖的原因在于日常饮食以快餐为主，而有助于肠道益生菌生长的高膳食纤维食物摄入不足,致使某些种类的肠道益生菌过度繁殖所致。因而对于益生菌产品还存在有很大的改善空间。
发明内容
针对上述现有技术中的不足，本发明提供了一种复合配比的益生菌粉及其制备方法，制备工艺简单，疗效好，安全无副作用。
本发明的上述目的是通过以下技术方案予以实现的。
一种复合配比的益生菌粉，由如下重量百分比的原料制备得到：复合益生菌粉30～35％、脱脂乳粉5～15％、酵母抽提物5～15％、麦芽糊精粉8～16％、燕麦β-葡聚糖5～10％、菊粉2～8％、甜菊糖3～6％、低聚果糖3～8％、聚葡萄糖3～6％、聚木糖2～10％；所述复合益生菌粉由植物乳杆菌粉、乳双歧杆菌粉、鼠李糖乳杆菌粉、干酪乳杆菌粉按质量比2～3:1～1.5:0.5～1.2:1组成。
优选的，所述复合益生菌粉由植物乳杆菌粉、乳双歧杆菌粉、鼠李糖乳杆菌粉、干酪乳杆菌粉按质量比3:1.5:0.9:1组成，其活菌数高于1012cfu/g，水分含量低于3％。
本发明将复合益生菌按一定比例优化复配，充分发挥四者之间的相互协同作用，对于调整体质、帮助消化、使排便顺畅、改变细菌丛生态、维持健康的效果显著。
脱脂乳粉：将鲜牛奶脱去脂肪再干燥而成，除脂肪可降低至1％左右外，其他变化不大。因其脂肪含量较少，所以易保存，不易发生氧化作用，适宜肥胖而又需要补充营养的人饮用，对于老年人，消化不良的婴儿，经及腹泻、胆囊疾患、高脂症、慢性胰腺炎等患者有一定益处。
酵母抽提物：富含多种氨基酸、多肽、呈味核苷酸、B族维生素、不含胆固醇和饱和脂肪酸。
燕麦β-葡聚糖：能够减少小肠对脂肪、碳水化合物及胆固醇的吸收率，从而降低血清胆固醇，具有降低血脂和血清胆固醇、增强免疫力的作用，对预防和治疗心脑血管疾病以及糖尿病有重要功效。
菊粉：具有降低血糖值、淡化血糖的浓度、增强消化和新陈代谢、改善血管障碍等功效，而且能量低，满足减肥养生的要求。
甜菊糖：是从菊科草本植物甜叶菊中精提的新型天然甜味剂。它具有高甜度、低热能的特点，其甜度是蔗糖的300倍，热值仅为蔗糖的1/300，经常食用可预防高血压、糖尿病、肥胖症、心脏病、龋齿等病症，是一种可替代蔗糖非常理想的甜味剂。
低聚果糖：是益生元的一种，具有热值低，有助于减肥，对糖尿病患者来说也是一种良好的甜味剂，具有防龋齿作用，对肠道益菌的增殖作用，可降低血清中胆固醇和甘油三酯的含量，促进营养的吸收，尤其是钙的吸收，防治腹泻和便秘等有益功效。
聚葡萄糖：具有不溶性膳食纤维所特有的明显增加粪便体积、增强通便、降低肠道癌的风险等的作用外，还能结合清除体内的胆酸，明显降低血清胆固醇，容易引致饱腹感，能明显降低饭后血糖水平等。
聚木糖：是聚合糖类中增殖益生菌功能最强的品种之一，它的功效性是其他聚合糖类的近20倍，人体胃肠道内没有水解低聚木糖的酶，所以其可直接进入大肠内优先为益生菌所利用，促进益生菌菌增殖同时产生多种有机酸。降低肠道PH值，抑制有害菌生长，使益生菌在肠道大量增殖，从而能够达到上述的保健功效。并且，低聚木糖对病原菌有较强的吸附力，如大肠杆菌、肠炎门氏菌、肺炎克雷伯氏菌、嗜水气单胞菌等都能吸附到低聚木糖上，由于低聚木糖不被肠道中的消化酶所降解，可携带附着的病原菌通过肠道排出体外，从而防止疾病在肠道中集群，达到防止腹泻的目的。
麦芽糊精粉：具有甜度低，无异味，易消化，低热，溶解性好，发酵性小，填充效果好，不易吸潮，增稠性强，载体性好，稳定性好，难以变质的特性。同时，其还含有大量的膳食纤维，是益生菌的良好载体，有利于调节人体肠道内益生菌数量平衡。另外还含有钙、铁等对人体有益的微量元素及矿物质，并能促进人体正常的物质代谢。
优选的，所述的一种复合配比的益生菌粉，由如下重量百分比的原料制备得到：复合益生菌粉32％、脱脂乳粉13％、酵母抽提物12％、麦芽糊精粉16％、燕麦β-葡聚糖6％、菊粉4％、甜菊糖4％、低聚果糖4％、聚葡萄糖4％、聚木糖5％。
优选的，所述的一种复合配比的益生菌粉的制备方法，所述制备方法包括如下步骤：
S1.按所述重量百分比称取麦芽糊精粉、燕麦β-葡聚糖、菊粉、甜菊糖、低聚果糖、聚葡萄糖、聚木糖进行混合，混合均匀后进行灭菌处理得组分A；
S2.向经步骤S1灭菌处理后的组分A中添加所述重量百分比的复合益生菌粉、脱脂乳粉、酵母抽提物，混合均匀，即制得成品。
更优选的，所述的一种复合配比的益生菌粉的制备方法，步骤S1中所述灭菌处理是在100～110℃条件下保温1～2小时。
优选的，所述的一种复合配比的益生菌粉的剂型为粉剂、颗粒剂或奶昔中的任意一种。
与现有技术相比，本发明有益效果在于：
(1)本发明通过将不同特性益生菌及不同营养源进行优化组合，优化配方，可在保证益生菌活菌数的前提下，生产出适宜不同消费群体营养需求的益生菌粉。这样不仅可以满足人体对益生菌活菌数的需求，还可通过复配生产出不同营养特征的方便型功能食品，制得的产品营养含量高，口感好，益生菌含量平衡，适合大多数人群的食用，对人体的消化系统和免疫系统都具有良好的辅助调节作用，产品市场前景广阔。
(2)本发明具有操作简便、运行可靠，产品贮运要求低、保质期长，生产效益高等优点。
具体实施方式
为了使本发明的目的、技术方案及优点更加清楚明白，以下结合实施例，对本发明进行进一步详细说明。应当理解，此处所描述的具体实施例仅仅用以解释本发明，并不用于限定本发明。除非特别说明，本发明采用的试剂、方法和设备为本技术领域常规试剂、方法和设备。
具体实施方式中所述的一种复合配比的益生菌粉的剂型为粉剂、颗粒剂或奶昔中的任意一种。
作为一种优选的制备方法，所述的一种复合配比的益生菌粉的制备方法如下：
S1.按所述重量百分比称取麦芽糊精粉、燕麦β-葡聚糖、菊粉、甜菊糖、低聚果糖、聚葡萄糖、聚木糖进行混合，混合均匀后进行灭菌处理得组分A；
S2.向经步骤S1灭菌处理后的组分A中添加所述重量百分比的复合益生菌粉、脱脂乳粉、酵母抽提物，混合均匀，即制得成品。
更优选的，所述的一种复合配比的益生菌粉的制备方法，步骤S1中所述灭菌处理是在100～110℃条件下保温1～2小时。
本发明各组分原料如未特别说明，均为采用现有方法制得，或直接购买现有商品。
以下以具体实施条件为例对本发明方法进行进一步说明。
实施例1
一种复合配比的益生菌粉，由如下重量百分比的原料制备得到：复合益生菌粉32％、脱脂乳粉13％、酵母抽提物12％、麦芽糊精粉16％、燕麦β-葡聚糖6％、菊粉4％、甜菊糖4％、低聚果糖4％、聚葡萄糖4％、聚木糖5％；所述复合益生菌粉由植物乳杆菌粉、乳双歧杆菌粉、鼠李糖乳杆菌粉、干酪乳杆菌粉按质量比3:1.5:0.9:1组成。
所述的一种复合配比的益生菌粉的制备方法如下：
S1.按所述重量百分比称取麦芽糊精粉、燕麦β-葡聚糖、菊粉、甜菊糖、低聚果糖、聚葡萄糖、聚木糖进行混合，混合均匀后在100℃条件下保温2小时进行灭菌处理得组分A；
S2.向经步骤S1灭菌处理后的组分A中添加所述重量百分比的复合益生菌粉、脱脂乳粉、酵母抽提物，混合均匀，即制得成品。
实施例2
一种复合配比的益生菌粉，由如下重量百分比的原料制备得到：复合益生菌粉35％、脱脂乳粉5％、酵母抽提物5％、麦芽糊精粉16％、燕麦β-葡聚糖10％、菊粉2％、甜菊糖6％、低聚果糖8％、聚葡萄糖3％、聚木糖10％；本实施例所述复合益生菌粉与实施例1相同。
制备方法与实施例1相同。
实施例3
一种复合配比的益生菌粉，由如下重量百分比的原料制备得到：复合益生菌粉30％、脱脂乳粉15％、酵母抽提物15％、麦芽糊精粉8％、燕麦β-葡聚糖5％、菊粉8％、甜菊糖3％、低聚果糖3％、聚葡萄糖6％、聚木糖7％；所述复合益生菌粉由植物乳杆菌粉、乳双歧杆菌粉、鼠李糖乳杆菌粉、干酪乳杆菌粉按质量比2:1:0.5:1组成。
制备方法与实施例1相同。
实施例4
一种复合配比的益生菌粉，由如下重量百分比的原料制备得到：复合益生菌粉32％、脱脂乳粉15％、酵母抽提物15％、麦芽糊精粉8％、燕麦β-葡聚糖5％、菊粉8％、甜菊糖3％、低聚果糖6％、聚葡萄糖6％、聚木糖2％；所述复合益生菌粉由植物乳杆菌粉、乳双歧杆菌粉、鼠李糖乳杆菌粉、干酪乳杆菌粉按质量比2.5:1:1.2:1组成。
制备方法与实施例1相同。
对比例1
一种复合配比的益生菌粉的配方基本与实施例1相同，不同之处在于所述复合益生菌粉的组成，所述复合益生菌粉由植物乳杆菌粉、乳双歧杆菌粉、鼠李糖乳杆菌粉、干酪乳杆菌粉按质量比3.5:1.8:1:1组成。
制备方法与实施例1相同。
对比例2
一种复合配比的益生菌粉，由如下重量百分比的原料制备得到：复合益生菌粉45％、脱脂乳粉5％、酵母抽提物5％、麦芽糊精粉5％、燕麦β-葡聚糖10％、菊粉2％、甜菊糖6％、低聚果糖9％、聚葡萄糖3％、聚木糖10％；本对比例所述复合益生菌粉与实施例1相同。
制备方法S1步骤中所述灭菌处理是在130℃条件下保温1小时，其余制备方法与实施例1相同。
应用例
随机抽取年龄在25-60岁之间的人群，男女不限共300人，分为6组，每组50人，分别饮用实施例1～4及对比例1～2的益生菌粉，坚持每天服用6个月，疗效判定标准：①显效：排便通畅次数规律、气色精神好、身体健康；②好转：排便较为规律、气色精神较好转；③无效：各方面无明显改善。调查结果如下表所示：
| 人数/例 | 显效/例 | 好转/例 | 无效/例 | 有效率/％ | |
| 实施例1 | 50 | 49 | 1 | 0 | 100 |
| 实施例2 | 50 | 46 | 3 | 1 | 98 |
| 实施例3 | 50 | 44 | 3 | 3 | 94 |
| 实施例4 | 50 | 45 | 2 | 3 | 94 |
| 对比例1 | 50 | 34 | 8 | 8 | 84 |
| 对比例2 | 50 | 31 | 10 | 9 | 82 |
由上表可知，本发明制备的产品效果显著，适合现代人长期饮用，能很好的益气补神，清肠通便，降低血脂，促进新陈代谢、提高免疫力、使人肌肤红润、精神焕发，改善现代人身体状况，起到保健作用；且本发明零蔗糖，零添加，纯天然工艺，糖尿病和高血糖患者亦可使用，能满足所有人群的养生保健需求，市场应用前景广泛。
以上所述，仅为本发明的说明实施例，并非对本发明任何形式上和实质上的限制，应当指出，对于本技术领域的普通技术人员，在不脱离本发明方法的前提下，做出的若干改进和补充也应视为本发明的保护范围。凡熟悉本专业的技术人员，在不脱离本发明精神和范围的情况下，利用以上所揭示的技术内容做出的些许更改、修饰与演变的等同变化，均为本发明的等效实施例；同时，凡依据本发明的实质技术对上述实施例所做的任何等同变化的更改、修饰与演变，均仍属于本发明的保护范围。
Claims (6)
1.一种复合配比的益生菌粉，其特征在于，由如下重量百分比的原料制备得到：复合益生菌粉30～35％、脱脂乳粉5～15％、酵母抽提物5～15％、麦芽糊精粉8～16％、燕麦β-葡聚糖5～10％、菊粉2～8％、甜菊糖3～6％、低聚果糖3～8％、聚葡萄糖3～6％、聚木糖2～10％；所述复合益生菌粉由植物乳杆菌粉、乳双歧杆菌粉、鼠李糖乳杆菌粉、干酪乳杆菌粉按质量比2～3:1～1.5:0.5～1.2:1组成。
2.根据权利要求1所述的一种复合配比的益生菌粉，其特征在于，所述复合益生菌粉由植物乳杆菌粉、乳双歧杆菌粉、鼠李糖乳杆菌粉、干酪乳杆菌粉按质量比3:1.5:0.9:1组成，其活菌数高于1012cfu/g，水分含量低于3％。
3.根据权利要求1或2所述的一种复合配比的益生菌粉，其特征在于，由如下重量百分比的原料制备得到：复合益生菌粉32％、脱脂乳粉13％、酵母抽提物12％、麦芽糊精粉16％、燕麦β-葡聚糖6％、菊粉4％、甜菊糖4％、低聚果糖4％、聚葡萄糖4％、聚木糖5％。
4.权利要求1所述的一种复合配比的益生菌粉的制备方法，其特征在于，所述制备方法包括如下步骤：
S1.按所述重量百分比称取麦芽糊精粉、燕麦β-葡聚糖、菊粉、甜菊糖、低聚果糖、聚葡萄糖、聚木糖进行混合，混合均匀后进行灭菌处理得组分A；
S2.向经步骤S1灭菌处理后的组分A中添加所述重量百分比的复合益生菌粉、脱脂乳粉、酵母抽提物，混合均匀，即制得成品。
5.根据权利要求4所述的一种复合配比的益生菌粉的制备方法，其特征在于，步骤S1中所述灭菌处理是在100～110℃条件下保温1～2小时。
6.根据权利要求1所述的一种复合配比的益生菌粉，其特征在于，所述的益生菌粉的剂型为粉剂、颗粒剂或奶昔中的任意一种。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710909932.1A CN107647410A (zh) | 2017-09-29 | 2017-09-29 | 一种复合配比的益生菌粉及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710909932.1A CN107647410A (zh) | 2017-09-29 | 2017-09-29 | 一种复合配比的益生菌粉及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107647410A true CN107647410A (zh) | 2018-02-02 |
Family
ID=61115942
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710909932.1A Pending CN107647410A (zh) | 2017-09-29 | 2017-09-29 | 一种复合配比的益生菌粉及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107647410A (zh) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110338402A (zh) * | 2018-04-08 | 2019-10-18 | 王康学 | 一种复合益生菌粉及其制备方法 |
| CN112391303A (zh) * | 2019-08-15 | 2021-02-23 | 广东长兴生物科技股份有限公司 | 一种双歧杆菌菌粉及其益生菌的制备工艺 |
| CN112400948A (zh) * | 2020-11-18 | 2021-02-26 | 谢景彬 | 一种酸奶低温蛋糕的配方及制作工艺 |
| CN115537362A (zh) * | 2022-11-23 | 2022-12-30 | 南京捷诺生物制品有限公司 | 调节人体微生态的复合菌及其制备方法和应用 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105454966A (zh) * | 2015-12-11 | 2016-04-06 | 苏州泽达兴邦医药科技有限公司 | 改善胃肠道且提高免疫力的益生菌固体饮料及其制备方法 |
| CN105918748A (zh) * | 2016-05-20 | 2016-09-07 | 南京汉钦食品有限公司 | 一种益生菌膳食纤维固体饮料及其制备方法 |
| CN106072657A (zh) * | 2016-06-08 | 2016-11-09 | 天津隆顺榕发展制药有限公司 | 益生菌组合物及其制备方法 |
-
2017
- 2017-09-29 CN CN201710909932.1A patent/CN107647410A/zh active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105454966A (zh) * | 2015-12-11 | 2016-04-06 | 苏州泽达兴邦医药科技有限公司 | 改善胃肠道且提高免疫力的益生菌固体饮料及其制备方法 |
| CN105918748A (zh) * | 2016-05-20 | 2016-09-07 | 南京汉钦食品有限公司 | 一种益生菌膳食纤维固体饮料及其制备方法 |
| CN106072657A (zh) * | 2016-06-08 | 2016-11-09 | 天津隆顺榕发展制药有限公司 | 益生菌组合物及其制备方法 |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110338402A (zh) * | 2018-04-08 | 2019-10-18 | 王康学 | 一种复合益生菌粉及其制备方法 |
| CN112391303A (zh) * | 2019-08-15 | 2021-02-23 | 广东长兴生物科技股份有限公司 | 一种双歧杆菌菌粉及其益生菌的制备工艺 |
| CN112391303B (zh) * | 2019-08-15 | 2022-04-15 | 广东长兴生物科技股份有限公司 | 一种双歧杆菌菌粉及其益生菌的制备工艺 |
| CN112400948A (zh) * | 2020-11-18 | 2021-02-26 | 谢景彬 | 一种酸奶低温蛋糕的配方及制作工艺 |
| CN115537362A (zh) * | 2022-11-23 | 2022-12-30 | 南京捷诺生物制品有限公司 | 调节人体微生态的复合菌及其制备方法和应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107594279A (zh) | 一种益生菌粉固体饮料及其制备方法 | |
| Sarkar | Potentiality of probiotic yoghurt as a functional food–a review | |
| RU2543815C2 (ru) | Питательные композиции, содержащие лактоферрин и пробиотики, и наборы из их частей | |
| Mckinley | The nutrition and health benefits of yoghurt | |
| Hitchins et al. | Prophylactic and therapeutic aspects of fermented milk | |
| CN109430666A (zh) | 一种益生菌冻干粉固体饮料 | |
| CN104758318B (zh) | 一种降低断奶仔猪腹泻率的复合制剂及其制备方法 | |
| US20100166721A1 (en) | Probotic compositions and uses thereof | |
| US20110165127A1 (en) | Dairy-derived probiotic compositions and uses thereof | |
| Mofid et al. | Therapeutic and nutritional effects of synbiotic yogurts in children and adults: a clinical review | |
| Arshad et al. | Lactobacilli as probiotics and their isolation from different sources | |
| CN110338402A (zh) | 一种复合益生菌粉及其制备方法 | |
| CN107647410A (zh) | 一种复合配比的益生菌粉及其制备方法 | |
| CN108740251A (zh) | 一种改善便秘的益生菌凝胶糖果及其制备方法 | |
| CN108850397A (zh) | 一种止腹泻的益生菌凝胶糖果及其制备方法 | |
| CN105918748A (zh) | 一种益生菌膳食纤维固体饮料及其制备方法 | |
| CN108669563A (zh) | 一种组合物、其应用和增强免疫力、改善过敏的产品 | |
| CN105802876B (zh) | 一种复合益生菌发酵苜蓿嫩芽粉制剂及其制备方法和应用 | |
| Eliseeva | Curdled milk: composition and benefits proven by research | |
| CN102300472A (zh) | 共生组合物及其制备方法 | |
| CN106879739A (zh) | 一种含四类活菌的微生物发酵乳酸制剂及其制备方法 | |
| US20230405062A1 (en) | Gos pre-conditioning l. reuteri and gos in final formulation | |
| Hadjimbei et al. | Beneficial effects of yoghurts and probiotic fermented milks and their functional food potential. Foods. 2022; 11: 2691 | |
| JP2010265223A (ja) | 嫌気性発酵抑制剤 | |
| CN108850156A (zh) | 一种益生菌固体饮料及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180202 |
|
| RJ01 | Rejection of invention patent application after publication |